Literature DB >> 28930626

Pilot study: whole body manual subcutaneous adipose tissue (SAT) therapy improved pain and SAT structure in women with lipedema.

Karen L Herbst1, Christopher Ussery2, Alyna Eekema3.   

Abstract

Background Lipedema is a common painful subcutaneous adipose tissue (SAT) disorder in women affecting the limbs. SAT therapy is a manual therapy to improve soft tissue quality. Objective Determine if SAT therapy improves pain and structure of lipedema SAT. Design Single arm prospective pilot study. Setting Academic medical center. Patients Seven women, 46 ± 5 years, weight 90 ± 19 kg, with lipedema. Intervention Twelve 90-min SAT therapy sessions over 4 weeks. Outcomes Dual X-ray absorptiometry (DXA) scans, SAT ultrasound (Vevo 2100), leg volumetrics, skin caliper assessment, tissue exam, weight, resting metabolic rate, pain assessment, lower extremity functional scale (LEFS) and body shape questionnaire (BSQ) at baseline and end of study. Results Weight, resting metabolic rate and BSQ did not change significantly. Limb fat over total body fat mass (p = 0.08) and trunk fat over total body mass trended down from baseline (p = 0.08) by DXA. Leg volume and caliper assessments in eight of nine areas (p < 0.007), LEFS (p = 0.002) and average pain (p = 0.007) significantly decreased from baseline. Fibrosis significantly decreased in the nodules, hips and groin. Ultrasound showed improved SAT structure in some subjects. Side effects included pain, bruising, itching, swelling and gastroesophageal reflux disease. All women said they would recommend SAT therapy to other women with lipedema. Limitations Small number of subjects. Conclusion SAT therapy in 4 weeks improved tissue structure, perceived leg function, and volume although shape was not affected. While side effects of SAT therapy were common, all women felt the therapy was beneficial.

Entities:  

Keywords:  fat; lipedema; pain; subcutaneous adipose tissue; women’s health

Mesh:

Year:  2017        PMID: 28930626     DOI: 10.1515/hmbci-2017-0035

Source DB:  PubMed          Journal:  Horm Mol Biol Clin Investig        ISSN: 1868-1883


  6 in total

1.  Lipedema and Dercum's Disease: A New Application of Bioimpedance.

Authors:  Rachelle Crescenzi; Paula M C Donahue; Sandra Weakley; Maria Garza; Manus J Donahue; Karen L Herbst
Journal:  Lymphat Res Biol       Date:  2019-08-13       Impact factor: 2.589

2.  Physical Therapy in Women with Early Stage Lipedema: Potential Impact of Multimodal Manual Therapy, Compression, Exercise, and Education Interventions.

Authors:  Paula M C Donahue; Rachelle Crescenzi; Kalen J Petersen; Maria Garza; Niral Patel; Chelsea Lee; Sheau-Chiann Chen; Manus J Donahue
Journal:  Lymphat Res Biol       Date:  2021-11-08       Impact factor: 2.349

Review 3.  Lipedema: friend and foe.

Authors:  Yanira Sanchez-De la Torre; Rita Wadeea; Victoria Rosas; Karen L Herbst
Journal:  Horm Mol Biol Clin Investig       Date:  2018-03-09

4.  Increase in Leptin and PPAR-γ Gene Expression in Lipedema Adipocytes Differentiated in vitro from Adipose-Derived Stem Cells.

Authors:  Sara Al-Ghadban; Zaidmara T Diaz; Hallie J Singer; Karya B Mert; Bruce A Bunnell
Journal:  Cells       Date:  2020-02-12       Impact factor: 6.600

Review 5.  A Scoping Review of Available Tools in Measurement of the Effectiveness of Conservative Treatment in Lipoedema.

Authors:  Monika Czerwińska; Jacek Teodorczyk; Rita Hansdorfer-Korzon
Journal:  Int J Environ Res Public Health       Date:  2022-06-10       Impact factor: 4.614

6.  Standard of care for lipedema in the United States.

Authors:  Karen L Herbst; Linda Anne Kahn; Emily Iker; Chuck Ehrlich; Thomas Wright; Lindy McHutchison; Jaime Schwartz; Molly Sleigh; Paula Mc Donahue; Kathleen H Lisson; Tami Faris; Janis Miller; Erik Lontok; Michael S Schwartz; Steven M Dean; John R Bartholomew; Polly Armour; Margarita Correa-Perez; Nicholas Pennings; Edely L Wallace; Ethan Larson
Journal:  Phlebology       Date:  2021-05-28       Impact factor: 1.740

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.